drugset / Trial / NCT00633425

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

NCT00633425

Phase 4 Completed 43 enrolled Sanofi
RandomizedSingle-groupOpen-labelTreatment

Summary

Analyse the glucose profile, based on continuous glucose monitoring by CGMS, in type 2 diabetics inadequately controlled by metformin, before and after the addition of Glimepiride.

Timeline

Start
2002-10
Primary completion
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Glimepiride Small molecule